EUVIMEDEUVIMED entdecken
Crossref

A novel Fc-optimized anti-Ebola neutralizing antibody with extended in vivo half-life

Shangde Peng, Zihan Yi, Wen Hu, Fenghao Peng, Xinyi Zhou, Jiannan Feng, Na Wang, Yan Wen, Guojiang Chen, Chunxia Qiao

Microbial Pathogenesis · 2026

DOI: 10.1016/j.micpath.2026.108798 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2026. Verfasst von Shangde Peng und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology, Campus of Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212100, China; State Key Laboratory of National…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Antibodies, Monoclonal, Antibodies, Viral, Ebolavirus. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Provincial Agricultural Science and Technology Innovation Fund, Foundation for Innovative Research Groups of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingAntibodies, MonoclonalAntibodies, ViralEbolavirusImmunoglobulin Fc FragmentsHemorrhagic Fever, EbolaAnimalsHumansHalf-LifeReceptors, FcMiceMice, TransgenicHistocompatibility Antigens Class IMolecular Docking SimulationFemaleNeutralization Tests

Stichwörter der Autor:innen

EBOVFc optimizationHalf-lifeMab114

Substanzen

Antibodies, NeutralizingAntibodies, MonoclonalAntibodies, ViralReceptors, FcImmunoglobulin Fc FragmentsHistocompatibility Antigens Class IFc receptor, neonatal

Autor:innen und Institutionen

  • College of Biotechnology, Campus of Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212100, China; State Key Laboratory of National Security Specially Needed Medicines, Beijing, 100039, China.
  • College of Biotechnology, Campus of Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212100, China.
  • State Key Laboratory of National Security Specially Needed Medicines, Beijing, 100039, China.
  • College of Biotechnology, Campus of Jiangsu University of Science and Technology, Zhenjiang, Jiangsu, 212100, China. Electronic address: wenyan@just.edu.cn.
  • State Key Laboratory of National Security Specially Needed Medicines, Beijing, 100039, China. Electronic address: jky62033@163.com.
  • State Key Laboratory of National Security Specially Needed Medicines, Beijing, 100039, China. Electronic address: bioqcx@126.com.

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Provincial Agricultural Science and Technology Innovation Fund
  • Foundation for Innovative Research Groups of the National Natural Science Foundation of China
  • Graduate Research and Innovation Projects of Jiangsu Province

Zitieren

APA

Peng, S., Yi, Z., Hu, W., Peng, F., Zhou, X., Feng, J., Wang, N., Wen, Y., Chen, G., & Qiao, C. (2026). A novel Fc-optimized anti-Ebola neutralizing antibody with extended in vivo half-life. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2026.108798

Vancouver

Peng S, Yi Z, Hu W, Peng F, Zhou X, Feng J, et al. A novel Fc-optimized anti-Ebola neutralizing antibody with extended in vivo half-life. Microbial Pathogenesis. 2026. doi:10.1016/j.micpath.2026.108798

BibTeX
@article{Peng2026,
  author = {Peng, Shangde and Yi, Zihan and Hu, Wen and Peng, Fenghao and Zhou, Xinyi and Feng, Jiannan and Wang, Na and Wen, Yan and Chen, Guojiang and Qiao, Chunxia},
  title = {A novel Fc-optimized anti-Ebola neutralizing antibody with extended in vivo half-life},
  journal = {Microbial Pathogenesis},
  year = {2026},
  doi = {10.1016/j.micpath.2026.108798}
}
Kostenlos starten →